The world has changed in such a short period of time. The dire situation in which we find ourselves is driving a need for change in employee and retiree healthcare delivery. When it comes to wide-scale population health, appropriately and competently communicating with employees and program members has never been more important.
The Center for Disease Control and Prevention (CDC) has provided a list of those at higher risk for severe illness from COVID-19. This includes men and women aged 65 years and older, individuals who live in a nursing home or long-term care facility, and people of all ages with underlying medical conditions, specifically poorly or unmanaged issues. How can these individuals obtain a better understanding of some of the ways they can impact their own health? And what are the tools patients and their healthcare providers can use to facilitate this, such as genetics, which can provide insight into the right medicines before they are needed?
Jeffrey Shaman, PhD, MS, Chief Science Officer at Coriell Life Sciences, discusses implementation and early insights of genetics and public healthcare utilization.
Jay Wohlgemuth, MD, who is the Chief Medical Officer & SVP, R&D, Medical and Population Health with Quest Diagnostics, focuses on the factors that will be driving change in employee and retiree healthcare delivery in the post-pandemic world.
Gary Harbin, Executive Secretary of the Teachers’ Retirement System of Kentucky, explains their medication risk management program, driven by genetic testing and administered by Coriell, which has helped the system to dramatically improve retirees’ health, reduce adverse drug reactions, and lower overall costs.